Skip to main content
Rural Health Information Hub

Medication Assisted Treatment - Prescription Drug and Opioid Addiction

This funding record is inactive. Please see the program website or contact the program sponsor to determine if this program is currently accepting applications or will open again in the future.

 
Catalog of Federal Domestic Assistance Number: 93.243
Sponsors
Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services
Deadlines
Apr 29, 2022
Contact

For program issues:
Fred Bamfo
240.276.2423
Fred.Bamfo@samhsa.hhs.gov

For grants management and budget issues:
240.276.1400
foacsat@samhsa.hhs.gov

For grant review process and application status questions:
Angela Houde
240.276.1091
Angela.Houde@samhsa.hhs.gov

Purpose

The Medication Assisted Treatment - Prescription Drug and Opioid Addiction (Short Title: MAT-PDOA) program provides funding to expand or enhance access to medications for opioid use disorder (MOUD).

Required activities include:

  • Provide MOUD with at least one of the FDA-approved medications in combination with comprehensive psychosocial services, counseling, behavioral therapies, recovery support services (RSS), and other clinically appropriate services
  • Conduct clinical assessment to establish the diagnosis and severity level of OUD based on DSM-5 diagnostic criteria and with information necessary to identify a recommended level of care and develop an individualized treatment and recovery plan
  • Check the state, county, or local Prescription Drug Monitoring Program (PDMP), where available, for each new patient admission in compliance with any relevant state rules or regulations
  • Conduct screening and assessment for co-occurring substance use and mental disorders and develop a plan to either deliver or coordinate any services determined to be necessary to address any identified co-occurring disorders
  • Develop and implement outreach and engagement strategies to increase access to MOUD and related services for diverse populations with OUD
  • Ensure all applicable practitioners working on the grant-funded project obtain a DATA waiver to prescribe buprenorphine to more than 30 patients
  • Build funding mechanisms and service delivery models with rural and resource-limited counties and municipalities
  • Use telehealth services, or other innovative interventions, to reach, engage, and retain patients in treatment
  • Provide or develop formal partnerships to provide RSS, including peer recovery support services designed to improve access to and retention in care with MOUD and facilitate long-term recovery
  • Provide harm reduction services on site, either singularly or in collaboration with a community-based harm reduction organization
Eligibility

Eligible applicants include domestic public and private nonprofit entities, including federally recognized tribes and tribal organizations.

Geographic coverage
Nationwide and U.S. territories
Amount of funding

Award ceiling: Up to $750,000
Project period: Up to 5 years
Estimated number of awards: 30
Estimated total program funding: $22,575,000

At least $11,000,000 is set aside for federally recognized American Indian/Alaska Native (AI/AN) tribes/tribal organizations if application volume from tribes/tribal organizations permits.

Application process

Links to the full announcement, application instructions, and the online application process are available through grants.gov.

Tagged as
American Indian or Alaska Native · Prescription drug misuse · Substance use and misuse · Telehealth

Organizations (2)

  • U.S. Department of Health and Human Services, view details
  • Substance Abuse and Mental Health Services Administration, view details



For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.